|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 3/12 | |
| A61P 19/08 | |||
| A61K 38/17 | |||
| A61K 38/29 | |||
| A61K 45/06 | |||
| A61K 31/59 | |||
| A61K 33/06 | |||
| A61K 33/42 | |||
| A61K 31/506 |
| (11) | Number of the document | 2830626 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13712589.4 |
| Date of filing the European patent application | 2013-03-29 | |
| (97) | Date of publication of the European application | 2015-02-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/056811 |
| Date | 2013-03-29 |
| (87) | Number | WO 2013/144339 |
| Date | 2013-10-03 |
| (30) | Number | Date | Country code |
| 201261617889 P | 2012-03-30 | US |
| (72) |
KNEISSEL, Michaela, CH
GUAGNANO, Vito, CH
GRAUS PORTA, Diana, CH
WÖHRLE, Simon, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS |
| FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS |